The initial studies that led to the cure of Hodgkin's disease and diffuse large B-cell lymphomas set a paradigm of cancer treatment broadly applicable to a number of malignancies. In recent times our knowledge of the biology of the Immune system has clarified the origin of subsets of ...
The treatment of Hodgkin lymphoma has improved dramatically over the last 20 years, with advances in imaging techniques. In the early stages, this cancer of the immune system can be cured with a 95 percent success rate by a combination of radiation and chemotherapy. The major challenge is choos...
Kaposi's sarcoma, non-Hodgkin's lymphoma, Hodgkin's disease, and squamous cell carcinoma are among the malignancies seen with increased frequency in patients infected with HIV. The outlook for patients with these malignancies has improved significantly with the utilization of highly active antiretroviral...